Remote monitoring for myasthenia gravis patients
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study tests whether remote monitoring through smartphone apps can effectively track myasthenia gravis symptoms and help manage care from home, instead of frequent in-person visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of autoimmune myasthenia gravis.
- You have been seen at the study center within the last 3 years.
- Your MG severity is mild to moderate (MGFA class 1 to 4a), not severe or in remission.
- You have reliable internet access and a compatible smartphone.
- You live in the DC, Maryland, or Virginia area and plan to stay for the next year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to track your generalized myasthenia gravis (gMG) using a smartphone app and a wearable activity monitor. It’s not testing a drug – it’s about improving how doctors monitor your condition remotely, which might help you better manage your symptoms.
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
This study uses wearable sensors to track symptoms of myasthenia gravis in daily life. The goal is to see if these devices can better monitor how the disease changes over time.
This study uses your smartphone to record symptoms like slurred speech, hoarseness, arm fatigue, or droopy eyelids, making it easier for doctors to understand and monitor myasthenia gravis. Both people with MG and healthy volunteers can take part.
This study uses digital tools like questionnaires and smartphone tests to measure how myasthenia gravis affects you. It aims to create a better way for doctors to track your symptoms and adjust treatment.
This study is a patient registry that tracks the experiences of people with myasthenia gravis over time. It aims to better understand the condition and improve care, using a smartphone, tablet, or computer to share information.
Hear when a new Myasthenia Gravis (MG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.